GlassScriptPhysician profile
Russell Jay Buttars
NPI 1043428634
$5,709.28
in general payments reported to CMS, 2019-2025
12 companies · $67.63 in 2025
The $67.63 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.06 · 2022: $4,698 · 2023: $91.67 · 2024: $840 · 2025: $67.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $538 · Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $538.29 |
| Food and Beverage | $461.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,870.40 | 2022 | |
| Active Medical, LLC | $1,827.20 | 2022 | |
| Paragon 28, INC. | $743.96 | 2024-2025 | Apex 3d, Additive Orthopedics, Portfolio |
| Nevro Corp. | $67.08 | 2023 | Senza |
| Stryker Corporation | $39.16 | 2024 | Invision |
| Solventum Corporation | $33.84 | 2024 | Prevena, V.A.C. Veraflo |
| Nalu Medical, INC. | $30.64 | 2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $25.23 | 2024 | Qutenza |
| Vericel Corporation | $24.59 | 2023 | Maci |
| Ani Pharmaceuticals, INC. | $21.99 | 2025 | Purified Cortrophin Gel |
| Treace Medical Concepts, INC. | $13.13 | 2024 | |
| Ferring Pharmaceuticals INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Buttars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.